Skip to main content
    R

    Replimune Group Inc (REPL)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $19.69
    -1.72 (-8.03%)

    Market Cap: $2.03B

    Last updated: Nov 17, 2026 at 4:27 PM ET

    Replimune Group Inc (REPL) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Replimune Group (REPL) has a latest price of $19.69 on Nov 17, 2026, 16.4% below its 52-week high of $23.54. Its price rose 119.0% over the past 12 months. The month-end price rose 17.5% since Jul 2018, a compound annual rate of 2.0%.

    Price Chart

    From Jul 2018 to Oct 2026, its highest month-end close was $51.68 in Nov 2020 and its lowest $2.57 in Apr 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart REPL with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for REPL.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 33.0%, and over 6 months it rose 318.9%. The month-end price rose 20.9% over the 3 years through Oct 2026, a compound annual rate of 6.5%.

    PeriodChange
    1 month+78.2%
    3 months+33.0%
    6 months+318.9%
    12 months+119.0%
    12 months, with dividends+119.0%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+20.9%+6.5%
    5 years-40.3%-9.8%
    Since Jul 2018+17.5%+2.0%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 165.9%, and its weakest was 2023, when it fell 69.0%.

    YearCloseChange
    2026 through Oct 2026$17.61+81.2%
    2025$9.72-19.7%
    2024$12.11+43.7%
    2023$8.43-69.0%
    2022$27.20+0.4%
    2021$27.10-29.0%
    2020$38.15+165.9%
    2019$14.35+43.5%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 31.4% above its 50-day average of $14.99 and 94.4% above its 200-day average of $10.13.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$19.69
    52-week high$23.54-16.4%
    52-week low$1.50+1,212.7%
    50-day average$14.99+31.4%
    200-day average$10.13+94.4%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 88.6%.

    MeasureValue
    1-year beta0.51
    Largest fall, 1 year-84.2%
    Largest fall, 3 years-88.6%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About REPL

    What is REPL's 1-year price change?

    Replimune Group's price rose 119.0% over the past 12 months. With dividends included, the 12-month total return was 119.0%.

    What is REPL's 5-year price change?

    Replimune Group's month-end price fell 40.3% over the 5 years through Oct 2026, a compound annual decline of 9.8%. These figures leave out dividends.

    What is REPL's 52-week high and low?

    Replimune Group's 52-week high is $23.54 and its 52-week low is $1.50. Its latest price of $19.69 on Nov 17, 2026 is 16.4% below the high.

    What is REPL's beta?

    Replimune Group's 1-year beta against the S&P 500 is 0.51, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 84.2%.

    Is the REPL chart free?

    Yes. Advanced Charting for REPL is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.